A new literature review explores the emerging application of CAR-T cell therapy in treating people with Systemic Lupus ...

Fate Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the lupus treatment candidate FT819.

In a new letter, published in the Journal of the European Academy of Dermatology and Venereology, members of the lupus ...

A new study explores the relationship between frailty, the proportion of health deficits present in an individual, as ...

A new study published in The Journal of the American Heart Association provides insights to improve cardiovascular disease ...

We support everyone affected by lupus. Whether you are living with lupus, a parent, spouse or loved one - we're your partner on this journey. The Lupus Foundation of America provides education and ...

The purpose of this study is to evaluate the safety and efficacy of CNTY-101, an investigational “off-the-shelf” CD19 Chimeric Antigen Receptor (CAR) Natural Killer (NK)-cell therapy, in participants ...

Managing lupus can come with significant health care costs that can have a big impact on a person’s or family’s overall finances. And costs can be especially high during the diagnosis process. While ...